Painful tic convulsif and botulinum toxin;Tic convulsivo doloroso y toxina botulínica

Revista de Neurologia

Volumn 42, Issue 12, 2006, Pages 729-732

  Boscá Blasco, María E ^a   Burguera Hernandez J A ^a   Roig Morata, S ^a   Martinez Torres I ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Botulinum toxin; Convulsive tic; Cranial neuropathy; Hemifacial spasm; Tic douloureux; Trigeminal neuralgia

Indexed keywords

BACLOFEN; BENZODIAZEPINE; BOTULINUM TOXIN A; CLONAZEPAM;

ADULT; AGED; ARNOLD CHIARI MALFORMATION; ARTICLE; CASE REPORT; CONVULSION; CRANIAL NEUROPATHY; DISEASE ASSOCIATION; ELECTROMYOGRAM; FEMALE; HEMIFACIAL SPASM; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PAIN; TRIGEMINUS NEURALGIA; COMORBIDITY; CRANIAL NERVE; DRUG EFFECT; MIDDLE AGED; NERVE CELL; NERVE COMPRESSION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION; TIC;

AGED; BOTULINUM TOXIN TYPE A; COMORBIDITY; CRANIAL NERVES; FEMALE; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; NERVE COMPRESSION SYNDROMES; NEURONS; SYNAPTIC TRANSMISSION; TIC DISORDERS; TRIGEMINAL NEURALGIA;

EID: 33750105868     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4212.2006036     Document Type: Article

References (21)

1. Cushing H. The major trigeminal neuralgias and their surgical treatment based on experiences with 332 Gasserian operations. Am J Med Sci 1920; 160: 157-84.
2. Kobata H, Kondo A, Iwasaki K, Nishioka T. Combined hyperactive dysfunction syndrome of the cranial nerves: trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia: 11-year experience and review. Neurosurgery 1998; 43: 1351-62.
3. Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve 1998; 21: 1740-7.
4. Llaves-Estévez L, Chacón-Peña J, Martínez- Fernández E, Burguera-Hernández JA, Valero C. Espasmo hemifacial bilateral. A propósito de ocho casos. Rev Neurol 2002; 35: 401-3.
5. Campbell E, Keedy C. Hemifacial spasm: a note on the etiology in two cases. J Neurosurg 1947; 4: 342-7.
6. Perkin GD, Illingworth RD. The association of hemifacial spasm and facial pain. J Neurol Neurosurg Psychiatry 1989; 52: 663-5.
7. Linskey ME, Jho HD, Jannetta PJ. Microvascular decompression for trigeminal neuralgia caused by vertebrobasilar compression. J Neurosurg 1994; 81: 1-9.
8. Duff JM, Spinner RJ, Lindor NM, Dodick DW, Atkinson JLD. Familial trigeminal neuralgia and contralateral hemifacial spasm. Neurology 1999; 53: 216-8.
9. Harsh GR, Wilson CB, Hieshima GB, Dillon WP. Magnetic resonance imaging of vertebrobasilar ectasia in tic convulsif. J Neurosurg 1991; 74: 999-1003.
10. Peñarrocha M, Bagán-Sebastián JV, Milian MA, Burguera JA. Neuralgia idiopática del intermediario. Avances en Odontoestomatología 1993; 9: 481-4.
11. Díaz C, Burguera JA, Baquero M, Domínguez F. Espasmo hemifacial: tratamiento con toxina botulínica A. Rev Neurol 1994; 22: 1-4.
12. Micheli F, Scorticati MC, Raina G. Beneficial effects of botulinum toxin type A for patients with painful tic convulsif. Clin Neuropharmacol 2002; 25: 5.
13. Türk Ü, Ilhan S, Alp R, Sur H. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol 2005; 28: 161-2.
14. Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD, FACP. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 2005; 65: 1306-8.
15. Allam N, Brasil-Neto JP, Brown G, Tomaz C. Injections of botulinum toxin type A produce pain alleviation in intractable trigeminal neuralgia. Clin J Pain 2005; 21: 182-4.
16. Argoff C. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain 2002; 18 (Suppl 6): S177-81.
17. Klein AW. The therapeutic potential of botulinum toxin. Dermatol Surg 2004; 30: 452-5.
18. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004; 107: 125-33.
19. Allam N, Brasil-Neto JP, Brown G, Tomaz C. Injections of botulinum toxin type A produce pain alleviation in intractable trigeminal neuralgia. Clin J Pain 2005; 21: 182-4.
20. Bach-Rojecky L, Relja M, Lackovic Z. Botulinum toxin type A in experimental neuropathic pain. J Neural Transm 2005; 112: 215-9.
21. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neutoxicology 2005; 26: 785-93.